NCT07593040
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07593040
Title Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma (Moonlanding)
Acronym Moonlanding
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Reina Sofia Córdoba Andalusia 14004 Spain Details
Hospital Clinico Universitario Lozano Blesa Zaragoza Aragon 50009 Spain Details
Hospital Universitario Marques De Valdecilla Santander Cantabria 39008 Spain Details
Hospital Universitari Vall D Hebron Barcelona Catalonia 08035 Spain Details
Hospital Clinic De Barcelona Barcelona Catalonia 08036 Spain Details
Institut Catala D'oncologia L'Hospitalet de Llobregat Catalonia 08908 Spain Details
Parc Tauli Hospital Universitari Sabadell Catalonia 08208 Spain Details
Hospital Universitario Lucus Augusti Lugo Galicia 27003 Spain Details
Complejo Hospitalario Universitario De Ourense Ourense Galicia 32005 Spain Details
Hospital Universitario Ramon Y Cajal Madrid Madrid 28034 Spain Details
Hospital Universitario 12 De Octubre Madrid Madrid 28041 Spain Details
Hospital Universitario De Navarra Pamplona Navarre 31008 Spain Details
Hospital Universitario Central De Asturias Oviedo Principality of Asturias 33011 Spain Details
Hospital Universitario Y Politecnico La Fe Valencia Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field